Literature DB >> 12764588

[Monitoring of irradiated brain metastases using MR perfusion imaging and 1H MR spectroscopy].

Marc-André Weber1, M P Lichy, C Thilmann, M Günther, P Bachert, A A Maudsley, S Delorme, L R Schad, J Debus, H-P Schlemmer.   

Abstract

PURPOSE: In follow-up examinations of irradiated brain metastases conventional contrast-enhanced morphological MR imaging is often unable to distinguish between transient radiation effects, radionecrosis,and tumor recurrence. To evaluate changes of relative cerebral blood flow (rCBF) in irradiated brain metastases arterial spin-labeling techniques (ASL) were applied and compared to the outcome of (1)H MR spectroscopy and spectroscopic imaging ((1)H MRS, SI). PATIENTS AND METHODS: In 2 patients follow-up examinations of irradiated brain metastases were performed on a 1.5-T tomograph (average single dose: 20 Gy/80% isodose). Relative CBF values of gray matter (GM), white matter (WM),and metastases (Met) were measured by means of the ASL techniques ITS-FAIR and Q2TIPS. (1)H MRS was performed with PRESS 1500/135.
RESULTS: In both patients with initially hyperperfused metastases (Met/GM >1) the reduction of rCBF after stereotactic radiosurgery indicated response to treatment--even if the contrast-enhancing region increased--while increasing rCBF values indicated tumor progression. The findings were confirmed by (1)H MRS, SI and subsequent follow-up.
CONCLUSION: The ASL techniques ITS-FAIR and Q2TIPS are able to monitor changes of rCBF in irradiated brain metastases. The two cases imply a possible role for ASL-MR perfusion imaging and (1)H MR spectroscopy in differentiating radiation effects from tumor progression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12764588     DOI: 10.1007/s00117-003-0887-6

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  5 in total

Review 1.  [(1)H magnetic resonance spectroscopy (MRS) of the liver and hepatic malignant tumors at 3.0 Tesla].

Authors:  F Fischbach; M Thormann; J Ricke
Journal:  Radiologe       Date:  2004-12       Impact factor: 0.635

Review 2.  Efficacy of proton magnetic resonance spectroscopy in neurological diagnosis and neurotherapeutic decision making.

Authors:  Alexander Lin; Brian D Ross; Kent Harris; Willis Wong
Journal:  NeuroRx       Date:  2005-04

Review 3.  [Perfusion measurement using the T2* contrast media dynamics in neuro-oncology. Physical basics and clinical applications].

Authors:  M-A Weber; F Risse; F L Giesel; L R Schad; H-U Kauczor; M Essig
Journal:  Radiologe       Date:  2005-07       Impact factor: 0.635

4.  Radiological progression of cerebral metastases after radiosurgery: assessment of perfusion MRI for differentiating between necrosis and recurrence.

Authors:  Friso W A Hoefnagels; Frank J Lagerwaard; Esther Sanchez; Cornelis J A Haasbeek; Dirk L Knol; Ben J Slotman; W Peter Vandertop
Journal:  J Neurol       Date:  2009-03-10       Impact factor: 4.849

5.  Intensity modulated radiation therapy versus three-dimensional conformal radiation therapy for the treatment of high grade glioma: a dosimetric comparison.

Authors:  Shannon M MacDonald; Salahuddin Ahmad; Stefanos Kachris; Betty J Vogds; Melissa DeRouen; Alicia E Gittleman; Keith DeWyngaert; Maria T Vlachaki
Journal:  J Appl Clin Med Phys       Date:  2007-04-19       Impact factor: 2.102

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.